ARTICLE | Clinical News
Epoetin zeta: Phase III data
September 15, 2008 7:00 AM UTC
In a sub-analysis of pooled data from 2 double-blind Phase III trials comparing IV Retacrit vs. Erypo epoetin alfa in 37 patients with diabetic nephropathy and CKD with stable Hb levels (10.5-12.5 g/...